Tabula Rasa HealthCare, Inc. (TRHC) Income Statement Analysis

See more : Qingdao TGOOD Electric Co., Ltd. (300001.SZ) Income Statement Analysis – Financial Results

Complete financial analysis of Tabula Rasa HealthCare, Inc. (TRHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tabula Rasa HealthCare, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.

You may be interested

Balurghat Technologies Limited (BALTE.BO) Income Statement Analysis – Financial Results
Focus Minerals Limited (FCSUF) Income Statement Analysis – Financial Results
Taiwan FamilyMart Co., Ltd. (5903.TWO) Income Statement Analysis – Financial Results
Dongkuk Structures & Construction Company Limited (100130.KQ) Income Statement Analysis – Financial Results
Silver Hammer Mining Corp. (HAMR.CN) Income Statement Analysis – Financial Results

Tabula Rasa HealthCare, Inc. (TRHC)

Industry: Medical - Healthcare Information Services

Sector: Healthcare

Website: https://www.tabularasahealthcare.com

About Tabula Rasa HealthCare, Inc.

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Metric	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	299.52M	331.26M	297.22M	284.71M	204.27M	134.55M	94.06M	70.04M	48.43M	25.14M
Cost of Revenue	232.60M	233.36M	204.81M	181.36M	137.67M	93.66M	65.18M	49.13M	37.81M	20.92M
Gross Profit	66.91M	97.90M	92.41M	103.35M	66.60M	40.89M	28.89M	20.91M	10.62M	4.22M
Gross Profit Ratio	22.34%	29.56%	31.09%	36.30%	32.60%	30.39%	30.71%	29.86%	21.92%	16.79%
Research & Development	14.48M	19.79M	18.18M	21.74M	12.22M	5.63M	3.81M	2.88M	1.66M	1.34M
General & Administrative	74.97M	73.76M	65.38M	50.90M	28.18M	21.18M	11.83M	7.12M	3.97M	2.48M
Selling & Marketing	10.49M	25.97M	21.55M	25.27M	9.67M	5.54M	3.86M	2.88M	2.27M	1.78M
SG&A	85.47M	99.73M	86.93M	76.17M	37.85M	26.72M	15.69M	10.00M	6.24M	4.26M
Other Expenses	23.35M	47.71M	45.04M	34.28M	16.80M	0.00	639.00K	0.00	0.00	0.00
Operating Expenses	123.30M	167.23M	150.15M	132.19M	66.87M	41.86M	24.62M	16.81M	9.72M	6.71M
Cost & Expenses	355.90M	400.58M	354.96M	313.54M	204.54M	135.52M	89.79M	65.93M	47.53M	27.63M
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	9.03M	9.11M	20.74M	15.99M	906.00K	688.00K	4.49M	5.92M	1.35M	833.00K
Depreciation & Amortization	31.74M	47.71M	45.04M	34.28M	16.80M	9.51M	5.12M	3.93M	1.82M	1.12M
EBITDA	-24.64M	-21.62M	-20.35M	1.63M	16.53M	8.54M	3.89M	8.04M	2.71M	-1.76M
EBITDA Ratio	-8.23%	-6.53%	-4.27%	1.91%	8.09%	6.35%	9.98%	11.48%	5.60%	-5.46%
Operating Income	-56.38M	-69.32M	-57.74M	-28.83M	-49.74M	5.20M	4.55M	6.17M	107.00K	-2.49M
Operating Income Ratio	-18.82%	-20.93%	-19.43%	-10.13%	-24.35%	3.87%	4.84%	8.80%	0.22%	-9.91%
Total Other Income/Expenses	-20.56M	-9.11M	-20.74M	-15.99M	-906.00K	-688.00K	-10.26M	-6.64M	-2.41M	-1.38M
Income Before Tax	-76.95M	-78.43M	-86.13M	-48.64M	-50.65M	4.51M	-5.71M	-2.54M	-1.52M	-3.87M
Income Before Tax Ratio	-25.69%	-23.68%	-28.98%	-17.08%	-24.79%	3.35%	-6.07%	-3.62%	-3.13%	-15.40%
Income Tax Expense	389.00K	627.00K	-5.17M	-16.20M	-3.38M	-9.78M	541.00K	328.00K	-409.00K	833.00K
Net Income	-77.33M	-79.06M	-80.97M	-32.44M	-47.27M	14.30M	-6.25M	-2.86M	-1.11M	-3.87M
Net Income Ratio	-25.82%	-23.86%	-27.24%	-11.39%	-23.14%	10.63%	-6.64%	-4.09%	-2.29%	-15.40%
EPS	-3.18	-3.39	-3.71	-1.57	-2.48	0.76	-0.83	-0.29	-0.11	-0.39
EPS Diluted	-3.18	-3.39	-3.71	-1.57	-2.48	0.68	-0.54	-0.29	-0.11	-0.39
Weighted Avg Shares Out	24.29M	23.29M	21.82M	20.62M	19.10M	16.73M	7.49M	9.86M	9.86M	9.86M
Weighted Avg Shares Out (Dil)	24.29M	23.29M	21.82M	20.62M	19.10M	18.77M	11.59M	9.86M	9.86M	9.86M

IRobot and Tabula Rasa See Activist Action

September 16, 2022marketwatch.com

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.

Here Is Why Bargain Hunters Would Love Fast-paced Mover Tabula Rasa Healthcare (TRHC)

August 26, 2022zacks.com

Tabula Rasa Healthcare (TRHC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our...

Tabula Rasa HealthCare, Inc.'s (TRHC) CEO Calvin Knowlton on Q2 2022 Results -Earnings Call Transcript

August 5, 2022seekingalpha.com

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC ) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Kevin Dill - Corporate Counsel Calvin Knowlton - Founder, Chairman and Chief Executive Officer Orsula Knowlton - Founder, President and Chief...

Tabula Rasa Healthcare (TRHC) Reports Q2 Loss, Tops Revenue Estimates

August 4, 2022zacks.com

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -3,300% and 5.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Tabula Rasa Sees Better Than Expected Q2 Sales, Just As Investor Calls For Removal Of Top Executives

July 21, 2022benzinga.com

Tabula Rasa HealthCare Inc (NASDAQ: TRHC) expects Q2 sales of $72 – $73 million, exceeding the prior guidance range of $66 – $69 million and the consensus of $67.61 million. Gordon Tunstall, TRHC's Lead Independent Director, said that the Board and management...

Tabula Rasa HealthCare's (TRHC) CEO Calvin Knowlton on Q1 2022 Results -Earnings Call Transcript

May 6, 2022seekingalpha.com

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC ) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Kevin Dill – Corporate Counsel Calvin Knowlton – Founder, Chairman and Chief Executive Officer Orsula Knowlton – Founder, President and Chief...